Dashboard
Manage Tickers

IMNN Imunon, Inc.

Nasdaq imunon.com


$ 4.87 $ -0.04 (-0.81 %)    

Friday, 24-Oct-2025 13:52:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.92 $ 1.92 (0.31 %)
DIA $ 472.58 $ 2.71 (0.58 %)
SPY $ 677.99 $ 1.49 (0.22 %)
TLT $ 91.53 $ -0.03 (-0.03 %)
GLD $ 377.97 $ -0.71 (-0.19 %)
$ 4.91
$ 4.91
$ 4.80 x 200
$ 4.89 x 45
$ 4.86 - $ 4.91
$ 4.60 - $ 41.22
66,316
na
12.38M
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-19-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-25-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-29-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 03-27-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 03-24-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

imunon-to-present-new-translational-data-from-phase-2-ovation-2-clinical-trial-of-imnn-001-investigational-therapy-for-ovarian-cancer-at-sitc-40th-annual-meeting
IMUNON To Present New Translational Data F...
10/23/2025 14:12:46

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per planLAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE N...

imunon-to-host-investor-rd-day-on-november-10-2025-to-present-phase-3-imnn-001-ovarian-cancer-study-updates
IMUNON To Host Investor R&D Day On Novembe...
10/20/2025 12:06:44

Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025Program w...

reported-earlier-imunon-to-give-oral-presentations-highlighting-imnn-101-its-investigational-dna-plasmid-vaccine-based-on-the-companys-proprietary-placcine-technology-platform-at-leading-vaccine-conferences
Reported Earlier: Imunon To Give Oral Pres...
10/17/2025 15:41:37

LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company focused on developi...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

imunon-to-present-phase-3-ovation-3-clinical-trial-imnn-001-at-esmo-congress
IMUNON To Present Phase 3 OVATION 3 Clinic...
10/14/2025 12:21:05

Prestigious European Society for Medical Oncology Conference "trials-in-progress" sessionPivotal OVATION 3 trial of its...

imunon-presents-imnn-001-phase-2-translational-data-in-ovarian-cancer-results-showed-13-month-increase-in-overall-survival
IMUNON Presents IMNN-001 Phase 2 Translati...
09/22/2025 12:06:58

imunon-to-present-new-translational-data-from-phase-2-ovation-2-study-of-imnn-001-at-2025-aacr-special-conference-in-cancer-research
IMUNON To Present New Translational Data F...
09/19/2025 12:07:43

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept. ...

imunon-regains-nasdaq-compliance
IMUNON Regains Nasdaq Compliance
08/28/2025 12:08:30

imunon-q2-2025-eps-215-may-not-be-comparable-to-034-estimate-cash-and-cash-equivalents-were-47m-expected-to-provide-cash-runway-into-q4-2025
Imunon Q2 2025 EPS $(2.15) May Not Be Comp...
08/05/2025 12:04:47

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

insights-into-imunons-upcoming-earnings
Insights into Imunon's Upcoming Earnings
08/04/2025 21:03:29

imunon-imnn-stock-is-trending-wednesday-whats-going-on
IMUNON (IMNN) Stock Is Trending Wednesday:...
07/30/2025 15:48:30

Shares of IMUNON are trading higher Wednesday morning. The company announced a clinical milestone for its lead drug candidate, ...

imunon-doses-first-patient-in-phase-3-ovation-3-study-of-imnn-001-for-ovarian-cancer
IMUNON Doses First Patient In Phase 3 OVAT...
07/30/2025 12:07:53

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/24/2025 23:50:05

imunon-announces-1-for-15-reverse-stock-split-effective-july-25-2025
IMUNON Announces 1-For-15 Reverse Stock Sp...
07/23/2025 12:09:46

IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15

imunon-files-prospectus-to-register-additional-45m-in-common-stock-for-at-the-market-offering-increasing-total-to-10m
Imunon Files Prospectus To Register Additi...
07/22/2025 12:10:11

- SEC Filing

imunon-receives-nasdaq-panel-approval-to-execute-compliance-plan
IMUNON Receives Nasdaq Panel Approval To E...
07/15/2025 12:14:16

imunon-submits-plan-to-nasdaq-to-regain-compliance-with-minimum-bid-price-requirement
IMUNON Submits Plan To Nasdaq To Regain Co...
06/30/2025 12:11:31

imunon-highlights-presentation-of-translational-data-from-phase-2-ovation-2-study-of-imnn-001
IMUNON Highlights Presentation Of Translat...
06/18/2025 12:07:57

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION